Standard Treatment Options for Myelodysplastic Syndromes
Standard treatment options for myelodysplastic syndromes include:
- Supportive care with one or more of the following:
- Transfusion therapy.
- Erythropoiesis-stimulating agents.
- Antibiotic therapy.
- Treatments to slow progression to acute myeloid leukemia (AML):
- Chemotherapy with stem cell transplant.
Treatment of Therapy-Related Myeloid Neoplasms
Patients who were treated in the past with chemotherapy or radiation therapy may develop myeloid neoplasms related to that therapy. Treatment options are the same as for other myelodysplastic syndromes.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with adult myelodysplastic syndromes. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI Web site.